Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs459552
rs459552
APC
0.070 GeneticVariation BEFREE In a large Scottish case-control study, we investigated the effects of adenomatous polyposis coli (APC) Asp1822Val (rs459552) and APC Glu1317Gln substitutions on colorectal cancer (CRC) risk and whether these associations were influenced by lifestyle and dietary factors. 18375958

2008

dbSNP: rs459552
rs459552
APC
0.070 GeneticVariation BEFREE When independently assessed in 971 patients with colorectal cancer and 954 healthy control subjects, none of the identified missense APC alterations conferred a significantly increased risk for colorectal cancer, odds ratio (95 percent confidence intervals): S130G = 3.1 (0.29-32.25), E1317Q = 1.08 (0.59-2.74), G2502S = 1 (0.65-1.63), D1822V (heterozygous) = 0.79 (0.64-0.98), D1822V (homozygous) = 0.82 (0.63-1.27). 18612690

2008

dbSNP: rs150973053
rs150973053
APC
0.010 GeneticVariation BEFREE When independently assessed in 971 patients with colorectal cancer and 954 healthy control subjects, none of the identified missense APC alterations conferred a significantly increased risk for colorectal cancer, odds ratio (95 percent confidence intervals): S130G = 3.1 (0.29-32.25), E1317Q = 1.08 (0.59-2.74), G2502S = 1 (0.65-1.63), D1822V (heterozygous) = 0.79 (0.64-0.98), D1822V (homozygous) = 0.82 (0.63-1.27). 18612690

2008

dbSNP: rs2229995
rs2229995
APC
0.010 GeneticVariation BEFREE When independently assessed in 971 patients with colorectal cancer and 954 healthy control subjects, none of the identified missense APC alterations conferred a significantly increased risk for colorectal cancer, odds ratio (95 percent confidence intervals): S130G = 3.1 (0.29-32.25), E1317Q = 1.08 (0.59-2.74), G2502S = 1 (0.65-1.63), D1822V (heterozygous) = 0.79 (0.64-0.98), D1822V (homozygous) = 0.82 (0.63-1.27). 18612690

2008

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE Furthermore, APC I1307K carriers had greater numbers of adenomas and colorectal cancers per patient than noncarriers. 17854661

2007

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE The I1307K variant was found in 32 subjects with non-CRC (7.9%). 17920230

2007

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE Furthermore, APC I1307K carriers had greater numbers of adenomas and colorectal cancers per patient than noncarriers. 17854661

2007

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE The I1307K variant was found in 32 subjects with non-CRC (7.9%). 17920230

2007

dbSNP: rs1801166
rs1801166
APC
0.100 GeneticVariation BEFREE The APC E1317Q and I1307K polymorphisms in non-colorectal cancers. 17920230

2007

dbSNP: rs459552
rs459552
APC
0.070 GeneticVariation BEFREE These results suggest a significant interaction between the D1822V polymorphism and the dietary intakes of cholesterol, calcium, and fiber for CRC risk. 17556698

2007

dbSNP: rs121913331
rs121913331
APC
0.010 GeneticVariation BEFREE The nonsense mutation Arg1114X in APC gene was found in five of 43 CRC tumor tissues. 17653897

2007

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE We could find no group of Ashkenazi Jews with colorectal cancer for whom screening for I130</span>7K would be clinically useful. 16875934

2006

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE Here, we used this design to evaluate inherited susceptibility to prostate cancer associated with APC I1307K using data from the Molecular Epidemiology of Colorectal Cancer study. 16537703

2006

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE Here, we used this design to evaluate inherited susceptibility to prostate cancer associated with APC I1307K using data from the Molecular Epidemiology of Colorectal Cancer study. 16537703

2006

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE We could find no group of Ashkenazi Jews with colorectal cancer for whom screening for I130</span>7K would be clinically useful. 16875934

2006

dbSNP: rs1801166
rs1801166
APC
0.100 GeneticVariation BEFREE Given the substantial size of our study and the consistency of our findings with the results of our meta-analyses, we conclude that it is unlikely that APC E1317Q is associated with a clinically meaningful risk of colorectal cancer. 17119068

2006

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE While the I1307K APC mutation clearly confers an increased lifetime risk for colorectal cancer, there is a paucity of data on the natural history of colonic neoplasia in symptomatic and asymptomatic mutation carriers. 15733272

2005

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE This excess can partially be attributed to inherited factors that are over represented in this population, such as the APC variant I1307K, which is associated with a modest increase in colorectal cancer risk. 16195945

2005

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE The I1307K mutation is associated with a moderate excess risk for CRC, but age of onset seems not to be earlier and this variant is not associated with a multiple colonic polyp phenotype. 15929773

2005

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE There was no significant difference noted between I1307K carriers and noncarriers with regard to the percentage of patients with first-degree relatives with colorectal carcinoma. 15959913

2005

dbSNP: rs1801155
rs1801155
APC
0.800 GeneticVariation BEFREE Together with former evidence of I1307K being a risk factor for colorectal cancer, these data suggest that colonoscopic surveillance for colorectal adenomas and cancer may be warranted in I1307K carriers, even in the absence of other identifiable risk factors. 16228836

2005

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE While the I1307K APC mutation clearly confers an increased lifetime risk for colorectal cancer, there is a paucity of data on the natural history of colonic neoplasia in symptomatic and asymptomatic mutation carriers. 15733272

2005

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE There was no significant difference noted between I1307K carriers and noncarriers with regard to the percentage of patients with first-degree relatives with colorectal carcinoma. 15959913

2005

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE This excess can partially be attributed to inherited factors that are over represented in this population, such as the APC variant I1307K, which is associated with a modest increase in colorectal cancer risk. 16195945

2005

dbSNP: rs1463038513
rs1463038513
APC
0.100 GeneticVariation BEFREE Together with former evidence of I1307K being a risk factor for colorectal cancer, these data suggest that colonoscopic surveillance for colorectal adenomas and cancer may be warranted in I1307K carriers, even in the absence of other identifiable risk factors. 16228836

2005